Thursday, 14 November 2024 | 14:30 - 15:00
PANEL DISCUSSION: Optimizing portfolio based on risk and return assessment
Format:In-person
Location:Pavilion 1
Track:PORTFOLIO
- ASSESSING PORTFOLIO RISK
131 participants
In this panel discussions we will explore several approaches that helped biotech and pharma companies to optimize the portfolio: Based on the risk and return assessment, identifying opportunities to optimize the portfolio. This involves adjusting resource allocations, prioritizing or deprioritizing certain projects, or pursuing new partnerships or collaborations to mitigate risks or enhance returns.
3 speakers